Filter

171 - 180 of 400 Results

  • House Appropriations Committee Releases the FY22 State and Foreign Operations (SFOPs) Appropriations Bill

    Fact Sheet

    The House Committee on Appropriations released its FY 2022 State, Foreign Operations, and Related Programs (SFOPs) appropriations bill on June 28, 2021 and accompanying report on June 30, 2021. The SFOPs bill includes funding for U.S. global health programs at the State Department and the U.S. Agency for International Development (USAID). Funding for these programs, through the Global Health Programs (GHP) account, which represents the bulk of global health assistance, totaled $10.6 billion, an increase…

  • White House Releases Full FY 2022 Budget Request

    Fact Sheet

    President Biden released his full FY 2022 budget request to Congress on May 28, 2021 (an initial, topline discretionary FY 2022 budget proposal was released on April 9, 2021). The request includes an increase of almost $1 billion for global health programs, most of which (84%) is for global health security. Almost all other global health program areas were level-funded in the request, with the exception of small increases for maternal and child health (MCH)…

  • Historical Trends in U.S. Funding for Global Health

    Issue Brief

    To provide context for the release of the administration’s first, full budget request for FY 2022, this brief provides an overview of historical trends in U.S. global health funding, including changes in program-specific funding over time, the distribution between bilateral and multilateral support, and in the increasing use of emergency supplemental funding in response to outbreaks.

  • Ahead of Biden’s Budget Proposal, A New KFF Analysis Takes a Closer Look at Historical Trends in the Global Health Budget

    News Release

    On May 28th, President Biden will release his first detailed budget proposal, covering the fiscal year starting in October 2021. As the largest global health donor in the world, the new budget proposal will provide a glimpse into what the Biden administration will be prioritizing for global health. In preparation for the budget release, KFF released a new brief looking at the historical trends in US funding for global health. Since FY 2001, US global…

  • Putting U.S. Global COVID-19 Vaccine Donations in Context

    Policy Watch

    While some have praised the most recent U.S. donation announcement as an important development, others have said the U.S. could do much more, pointing to the large supply of doses the U.S. is building up and the slowing demand for vaccinations in the country.  In this policy watch, we sought to put the U.S. pledge of 80 million doses in further context.

  • Supply vs Demand: Which States are Reaching their COVID-19 Vaccine Tipping Points?

    Policy Watch

    This analysis examines overall COVID-19 vaccination levels and how the rate of vaccinations over the last week has changed at state-level and national level. There is significant variability by state in how many adults in the US have been vaccinated with at least one dose. Most states are also seeing a decline in the pace of vaccinations, indicating that they may be approaching the point when vaccine supply exceeds demand.

  • What Could the U.S. Do to Help Improve Global COVID-19 Vaccine Equity?

    News Release

    As India and other countries continue to grapple with major COVID-19 outbreaks even as cases decline in this country, there is increasing attention to the global role that could be played by the U.S. government.  This is particularly the case now that the U.S. will soon have enough COVID-19 vaccine doses to fully vaccinate everyone in the country, and has also purchased additional doses of vaccines not yet authorized in the U.S.  A new issue…

  • Global COVID-19 Vaccine Equity: U.S. Policy Options and Actions to Date

    Issue Brief

    This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies. We summarize what the administration has done to date in these areas and policy issues related to each.

  • Key Questions About COVID-19 Vaccine Mandates

    Issue Brief

    This issue brief explains the legal basis for vaccine mandates by the federal government, states, and private employers; highlights considerations for mandates while the COVID-19 vaccine is under an EUA; and discusses mandate exemptions based on disability or religious objection.